C364-0202 Screening compound: 7-methyl-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)furo[2,3-b]quinoline-2-carboxamide

C364-0202 Screening compound: 7-methyl-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)furo[2,3-b]quinoline-2-carboxamide
C364-0202 Screening compound: 7-methyl-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)furo[2,3-b]quinoline-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C364-0202
7-methyl-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)furo[2,3-b]quinoline-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C364-0202

Molecular Formula

C27H29N3O2 (C27 H29 N3 O2)

Compound Name

7-methyl-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)furo[2,3-b]quinoline-2-carboxamide

IUPAC name

7-methyl-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)furo[23-b]quinoline-2-carboxamide

SMILES

Cc1cccc(CN2CCC(CNC(c3cc4cc5ccc(C)cc5nc4o3)=O)CC2)c1

InChI

InChI=1S/C27H29N3O2/c1-18-4-3-5-21(12-18)17-30-10-8-20(9-11-30)16-28-26(31)25-15-23-14-22-7-6-19(2)13-24(22)29-27(23)32-25/h3-7,12-15,20H,8-11,16-17H2,1-2H3,(H,28,31)

InChI Key

CLCRASCYUFMXGU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD26964671

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.55

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.581

Distribution Coefficient, logD

3.089

Water Solubility, LogSw

-5.84

Polar Surface Area

45.181

Acid Dissociation Constant (pKa)

13.17

Base Dissociation Constant (pKb)

9.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

C364-0202 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C364-0202 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C364-0202?
Check Price and Availability of C364-0202, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C364-0202 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C364-0202
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C364-0202
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C364-0202 available by request